Comorbidities predict worse prognosis in patients with primary myelofibrosis

E-ISSN： 1097-0142|120|19|2996-3002

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.19, 2014-10, pp. : 2996-3002

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Driver mutations and prognosis in primary myelofibrosis: Mayo‐Careggi MPN alliance study of 1,095 patients

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 3, 2018-03 ,pp. : 348-355

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Degree of Anisocytosis Predicts Survival in Patients with Primary Myelofibrosis

Acta Haematologica, Vol. 136, Iss. 2, 2016-05 ,pp. : 98-100

Karger

Access to resources Recommend Favorite

Anisocytosis: A Classical Marker of Inflammation or a New Predictive Marker in Patients with Primary Myelofibrosis

Acta Haematologica, Vol. 136, Iss. 3, 2016-09 ,pp. : 191-192

Karger

Access to resources Recommend Favorite

Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 3, 2018-03 ,pp. : 257-263

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinicopathological characteristics and prognosis of patients with multiple primary melanomas

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 1, 2018-01 ,pp. : e44-e45

John Wiley & Sons Inc

Access to resources Recommend Favorite